Chronic Systolic Heart Failure Clinical Trial
Official title:
Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST）
Ivabradine acts by inhibiting the ionic If current that modulates the pacemaker activity of sinoatrial node cells. The aim of present study is to evaluate the efficacy and safety of IvabRadine hemisulfate Sustained-release Tablets versus placebo in patients with moderate to severe chronic systolic heart failure.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Suspended |
NCT04589065 -
SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)
|
N/A | |
| Completed |
NCT02248441 -
Effect of Remote Ischemic Conditioning in Patients With Chronic Ischemic Heart Failure
|
N/A | |
| Terminated |
NCT01439893 -
Study of Efficacy on Cardiac Remodeling of Recombinant Human Neuregulin-1 in Stable Chronic Systolic Heart Failure Patients
|
Phase 3 | |
| Recruiting |
NCT03504891 -
Cardiac MRI for Optimal Heart Failure Outcomes With CRT Upgrades
|
Phase 1 | |
| Active, not recruiting |
NCT04468529 -
Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure
|
Phase 3 | |
| Active, not recruiting |
NCT01639378 -
Renal Artery Denervation in Chronic Heart Failure Study
|
Phase 3 | |
| Recruiting |
NCT05949801 -
Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure
|
Phase 3 | |
| Completed |
NCT02809131 -
Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
|
Phase 3 |